Week 4: Liver Neoplasms and Autoimmune Hepatitis/Cholangiopathies Flashcards
benign hepatocellular neoplasms which may be detected from abdominal pain but are often detected incidentally on imaging
Hepatocellular Adenomas (HCA)
What molecular activation is most commonly associated with Hepatocellular Adenomas (HCA)
Beta-catenin
ID these features for b-catenin activated Hepatocellular Adenomas (HCA)
ID
b-catenin activated Hepatocellular Adenomas (HCA)
hepatocytes look relatively normal except that they are forming abnormal tube-like structures called pseudoacini (red circles)
ID
b-catenin activated Hepatocellular Adenomas (HCA)
increased cell atypia characterized by nuclei that are slightly increased in size relative to their cytoplasm (yellow arrows)
ID
b-catenin activated Hepatocellular Adenomas (HCA)
Nuclear B-catenin staining on IHC (yellow arrows). Normal nuclei appear blue
ID
Nuclear B-catenin staining on IHC (yellow arrows). Normal nuclei appear blue
ID
Hepatocellular Carcinoma (HCC)
What are common mutations in Hepatocellular Carcinoma (HCC)
- TERT (telomerase transcriptase) promoter
- CTNNB1 gene
- beta-catenin gene
- TP53 inactivations
ID
Hepatocellular Carcinoma (HCC)
distorted versions of normal architecture, including large pseudoacinar spaces (yellow arrow)
ID
Hepatocellular Carcinoma (HCC)
ID and staining
Normal Liver and Reticulin stain
terminal hepatic venule / central vein (orange arrow)
ID and staining
Hepatocellular Carcinoma (HCC) and Reticulin stain
fragmented/lost fibers (red elipses) and terminal hepatic venule / central vein (orange arrow)
HCC accounts for approximately 5.4% of all cancers
worldwide and is one of the most common cancers in
geographic regions with high rates of _____
Hepatitis B
Risk factors for Cholangiocarcinoma
- Primary sclerosing cholangitis
- liver fluke infection
- hepatolithiasis
- HBV and HCV
- MAFLD
ID
Cholangiocarcinoma (CAC)
What is a cholangiocarcinoma called when it occurs at the bifurcation of the left/right hepatic ducts
Klatskin tumor
This biopsy was taken from the bile ducts
ID
Cholangiocarcinoma (CAC)
impossible to distinguish cholangiocarcinoma from metastatic adenocarcinomas by histology alone